Real-time Estimate
Cboe BZX
10:28:35 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
20.72
USD
|
-3.45%
|
|
-17.76%
|
-69.41%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,267
|
2,301
|
2,424
|
1,253
|
724.4
|
229.5
|
-
|
Enterprise Value (EV)
1 |
1,175
|
2,126
|
2,314
|
1,166
|
630
|
51.92
|
19.22
|
P/E ratio
|
17
x
|
22.6
x
|
15.1
x
|
9.06
x
|
7.39
x
|
25.5
x
|
13.7
x
|
Yield
|
-
|
2.3%
|
2.71%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.78
x
|
2.46
x
|
1.59
x
|
0.78
x
|
0.68
x
|
0.35
x
|
0.35
x
|
EV / Revenue
|
1.65
x
|
2.27
x
|
1.52
x
|
0.73
x
|
0.59
x
|
0.08
x
|
0.03
x
|
EV / EBITDA
|
12.3
x
|
14.3
x
|
10.4
x
|
5.14
x
|
4.28
x
|
1.77
x
|
0.49
x
|
EV / FCF
|
15.8
x
|
15.3
x
|
38.4
x
|
6.55
x
|
-
|
1.74
x
|
0.56
x
|
FCF Yield
|
6.32%
|
6.55%
|
2.61%
|
15.3%
|
-
|
57.5%
|
178%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
11,564
|
11,718
|
11,574
|
10,865
|
10,777
|
10,695
|
-
|
Reference price
2 |
109.6
|
196.3
|
209.4
|
115.4
|
67.22
|
21.46
|
21.46
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/23/22
|
2/21/23
|
2/20/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
713.7
|
934.8
|
1,526
|
1,599
|
1,072
|
659.5
|
655.4
|
EBITDA
1 |
95.66
|
148.5
|
223.1
|
227
|
147.1
|
29.35
|
39.45
|
EBIT
1 |
91.04
|
141.2
|
216.2
|
216
|
134
|
7.4
|
18.05
|
Operating Margin
|
12.76%
|
15.1%
|
14.17%
|
13.51%
|
12.5%
|
1.12%
|
2.75%
|
Earnings before Tax (EBT)
|
92.36
|
134.3
|
216.1
|
184.1
|
128.8
|
-
|
22.25
|
Net income
1 |
77.92
|
102.9
|
164
|
143.6
|
99.42
|
9.25
|
17.15
|
Net margin
|
10.92%
|
11%
|
10.75%
|
8.98%
|
9.27%
|
1.4%
|
2.62%
|
EPS
2 |
6.430
|
8.680
|
13.89
|
12.73
|
9.100
|
0.8400
|
1.565
|
Free Cash Flow
1 |
74.2
|
139.3
|
60.34
|
177.9
|
-
|
29.85
|
34.25
|
FCF margin
|
10.4%
|
14.9%
|
3.95%
|
11.13%
|
-
|
4.53%
|
5.23%
|
FCF Conversion (EBITDA)
|
77.57%
|
93.83%
|
27.05%
|
78.38%
|
-
|
101.7%
|
86.82%
|
FCF Conversion (Net income)
|
95.23%
|
135.44%
|
36.78%
|
123.91%
|
-
|
322.7%
|
199.71%
|
Dividend per Share
|
-
|
4.520
|
5.680
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/23/22
|
2/21/23
|
2/20/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
377.8
|
417.6
|
453.3
|
390.4
|
337.2
|
349
|
296.2
|
235.9
|
191
|
174.7
|
163.7
|
162.5
|
158.6
|
162.5
|
157.8
|
EBITDA
1 |
46.37
|
57.53
|
61.12
|
52.09
|
56.22
|
64.49
|
42.07
|
28.92
|
19.58
|
11.2
|
9.65
|
-2.35
|
7.75
|
9.6
|
9.8
|
EBIT
1 |
46.84
|
55.09
|
58.39
|
49.24
|
53.27
|
53.51
|
38.71
|
25.51
|
16.23
|
9.267
|
4.15
|
-8.15
|
2.15
|
5.55
|
4.1
|
Operating Margin
|
12.4%
|
13.19%
|
12.88%
|
12.61%
|
15.79%
|
15.33%
|
13.07%
|
10.81%
|
8.5%
|
5.3%
|
2.54%
|
-5.02%
|
1.36%
|
3.42%
|
2.6%
|
Earnings before Tax (EBT)
1 |
46.75
|
54.98
|
48.8
|
47.88
|
32.41
|
53.33
|
39.12
|
26.55
|
9.802
|
11.58
|
5.3
|
-6.85
|
3.45
|
6.5
|
5.1
|
Net income
1 |
34.02
|
41.78
|
39.11
|
36.16
|
26.52
|
39.97
|
30.28
|
23.13
|
6.036
|
8.316
|
4.05
|
-5.75
|
2.7
|
5
|
3.9
|
Net margin
|
9%
|
10.01%
|
8.63%
|
9.26%
|
7.86%
|
11.45%
|
10.22%
|
9.81%
|
3.16%
|
4.76%
|
2.47%
|
-3.54%
|
1.7%
|
3.08%
|
2.47%
|
EPS
2 |
2.910
|
3.590
|
3.420
|
3.270
|
2.410
|
3.670
|
2.770
|
2.120
|
0.5500
|
0.7600
|
0.3700
|
-0.5300
|
0.2400
|
0.4550
|
0.3600
|
Dividend per Share
|
1.420
|
1.640
|
-
|
-
|
-
|
-
|
1.650
|
1.650
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
5/2/22
|
8/3/22
|
11/3/22
|
2/21/23
|
5/1/23
|
8/7/23
|
11/6/23
|
2/20/24
|
4/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
92.7
|
174
|
110
|
87.7
|
94.4
|
178
|
210
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
74.2
|
139
|
60.3
|
178
|
-
|
29.9
|
34.3
|
ROE (net income / shareholders' equity)
|
72.8%
|
78.5%
|
91.2%
|
80.3%
|
59%
|
3.7%
|
8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
48.6%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
337.2
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
10.1
|
5.89
|
34.2
|
16.7
|
-
|
7.8
|
9.2
|
Capex / Sales
|
1.41%
|
0.63%
|
2.24%
|
1.04%
|
-
|
1.18%
|
1.4%
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/23/22
|
2/21/23
|
2/20/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
21.46
USD Average target price
21.25
USD Spread / Average Target -0.98% Consensus |
1st Jan change
|
Capi.
|
---|
| -68.07% | 230M | | +10.73% | 7.96B | | +5.95% | 7.66B | | -0.58% | 5.88B | | -6.11% | 3.72B | | -13.21% | 3.47B | | -15.49% | 1.16B | | -26.41% | 1.12B | | +9.98% | 948M | | -11.42% | 905M |
Special Foods & Wellbeing Products
|